Back to KROS

ORBIMED ADVISORS LLC → KROS

ORBIMED ADVISORS LLC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$8.7M
Q3 2026
Peak value
$16.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.4M
Q1 2026$8.4M
Q2 2026$8.1M
Q3 2026$8.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$8.7M759.2K——
Q2 2026$8.1M759.2K——
Q1 2026$8.4M759.2K——
Q4 2025$16.4M804.2K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other ORBIMED ADVISORS LLC positions

EWTX

EDGEWISE THERAPEUTICS INC

$630.5M
EWTX

EDGEWISE THERAPEUTICS INC

$630.1M
EWTX

EDGEWISE THERAPEUTICS INC

$488.8M
ADRX

ADARX PHARMACEUTICALS INC

$482.7M
EWTX

EDGEWISE THERAPEUTICS INC

$385.1M
ELVN

ENLIVEN THERAPEUTICS INC

$343.9M
LLY

ELI LILLY & CO

$323.7M
ELVN

ENLIVEN THERAPEUTICS INC

$312M